TVGN:NASDAQTevogen Bio Holdings Inc. Analysis

Tevogen Inc. (TVGN) is trading at $7.05, comfortably above its 20‑day SMA of $5.13 but still below the 50‑day SMA of $7.49, indicating a short‑term bounce within a broader bearish framework (price < 200‑day SMA of $13.47). The RSI sits at 60, suggesting modest upward momentum, while the MACD histogram is positive and the signal line is labeled bullish, offering a technical hint of upside. However, the stock exhibits extreme 30‑day volatility of 143% and a high beta of ~2.0, underscoring pronounced price swings. Fundamentally, TVGN reports zero revenue, negative EBITDA of $‑21.0 M, and a cash deficit with $0.69 M cash versus $9.47 M debt, resulting in a negative book value per share ($‑4.47) and a negative price‑to‑book ratio. Recent corporate news highlights an upcoming annual meeting and ongoing strategic acquisition initiatives that could eventually support up to $100 M in combined annual revenue, providing a potential catalyst amid the current financial distress.